These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
x
|
QUARTERLY REPORT PURSUANT TO
SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF
1934
|
|
o
|
TRANSITION REPORT PURSUANT TO
SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF
1934
|
|
Delaware
|
86-0629024
|
|
|
(State
or Other Jurisdiction of Incorporation or Organization)
|
(IRS
Employer Identification No.)
|
|
Large
accelerated filer
|
ý
|
Accelerated
filer
|
¨
|
|
Non-accelerated
filer
|
¨
|
Smaller
reporting company
|
¨
|
|
Shares
Outstanding of Registrant’s Common Stock
|
|
|
Class
|
Outstanding
at
January
31, 2010
|
|
Common
Stock, $0.001 par value
|
184,235,381
shares
|
|
Page
|
||
|
PART
I. FINANCIAL INFORMATION
|
||
|
Item
1.
|
Financial
Statements (Unaudited)
|
|
| 17 | ||
| 34 | ||
| 35 | ||
|
PART
II. OTHER INFORMATION
|
||
| 35 | ||
| 36 | ||
|
CERTIFICATIONS
|
||
|
EXHIBITS
|
||
|
ASSETS
|
||||||||
|
December
31,
|
As
adjusted
March
31,
|
|||||||
|
2009
|
2009
|
|||||||
|
(Unaudited)
|
(See
Notes 1 and 2)
|
|||||||
|
Cash
and cash equivalents
|
$ | 361,291 | $ | 446,329 | ||||
|
Short-term
investments
|
716,683 | 943,616 | ||||||
|
Accounts
receivable, net
|
113,763 | 88,525 | ||||||
|
Inventories
|
112,784 | 131,510 | ||||||
|
Prepaid
expenses
|
14,124 | 11,447 | ||||||
|
Deferred
tax assets
|
73,744 | 75,681 | ||||||
|
Other
current assets
|
50,348 | 51,736 | ||||||
|
Total current
assets
|
1,442,737 | 1,748,844 | ||||||
|
Property,
plant and equipment, net
|
495,065 | 531,687 | ||||||
|
Long-term
investments
|
421,628 | 50,826 | ||||||
|
Goodwill
|
36,165 | 36,165 | ||||||
|
Intangible
assets, net
|
28,996 | 25,718 | ||||||
|
Other
assets
|
19,016 | 18,526 | ||||||
|
Total assets
|
$ | 2,443,607 | $ | 2,411,766 | ||||
|
LIABILITIES
AND STOCKHOLDERS' EQUITY
|
||||||||
|
Accounts
payable
|
$ | 38,387 | $ | 29,228 | ||||
|
Accrued
liabilities
|
49,165 | 42,486 | ||||||
|
Deferred
income on shipments to distributors
|
97,583 | 83,931 | ||||||
|
Total current
liabilities
|
185,135 | 155,645 | ||||||
|
Junior
convertible debentures
|
339,000 | 334,184 | ||||||
|
Long-term
income tax payable
|
53,967 | 70,051 | ||||||
|
Deferred
tax liability
|
377,647 | 365,734 | ||||||
|
Other
long-term liabilities
|
3,983 | 3,834 | ||||||
|
Stockholders’
equity:
|
||||||||
|
Preferred
stock, $0.001 par value; authorized 5,000,000 shares; no shares issued or
outstanding
|
--- | --- | ||||||
|
Common
stock, $0.001 par value; authorized 450,000,000 shares; 218,789,994 shares
issued and 184,234,148 shares outstanding at December 31, 2009;
218,789,994 shares issued and 182,769,124 shares outstanding at March 31,
2009
|
184 | 183 | ||||||
|
Additional
paid-in capital
|
1,275,123 | 1,273,876 | ||||||
|
Retained
earnings
|
1,253,977 | 1,299,317 | ||||||
|
Accumulated
other comprehensive income
|
2,712 | 4,312 | ||||||
|
Common
stock held in treasury: 34,555,846 shares at December 31, 2009; 36,020,870
shares at March 31, 2009
|
(1,048,121 | ) | (1,095,370 | ) | ||||
|
Total stockholders’
equity
|
1,483,875 | 1,482,318 | ||||||
|
Total liabilities and
stockholders’ equity
|
$ | 2,443,607 | $ | 2,411,766 | ||||
|
See
accompanying notes to condensed consolidated financial
statements
|
||||||||
|
Three
Months Ended December 31,
|
Nine
Months Ended December 31,
|
|||||||||||||||
|
2009
|
As
adjusted
2008
|
2009
|
As
adjusted
2008
|
|||||||||||||
|
(See
Note 2)
|
(See
Note 2)
|
|||||||||||||||
|
Net
sales
|
$ | 250,099 | $ | 192,166 | $ | 669,709 | $ | 730,044 | ||||||||
|
Cost
of sales (1)
|
104,103 | 87,379 | 303,938 | 297,507 | ||||||||||||
|
Gross
profit
|
145,996 | 104,787 | 365,771 | 432,537 | ||||||||||||
|
Operating
expenses:
|
||||||||||||||||
|
Research
and development (1)
|
30,332 | 26,973 | 87,536 | 89,868 | ||||||||||||
|
Selling,
general and administrative (1)
|
43,096 | 36,840 | 120,525 | 127,882 | ||||||||||||
|
Special
charges
|
--- | 500 | 1,238 | 500 | ||||||||||||
| 73,428 | 64,313 | 209,299 | 218,250 | |||||||||||||
|
Operating
income
|
72,568 | 40,474 | 156,472 | 214,287 | ||||||||||||
|
Other
income (expense):
|
||||||||||||||||
|
Interest
income
|
4,946 | 7,410 | 12,727 | 27,761 | ||||||||||||
|
Interest
expense
|
(7,763 | ) | (7,096 | ) | (23,312 | ) | (21,608 | ) | ||||||||
|
Other,
net
|
128 | (20,378 | ) | 7,929 | (15,962 | ) | ||||||||||
|
Income
before income taxes
|
69,879 | 20,410 | 153,816 | 204,478 | ||||||||||||
|
Income
tax provision (benefit)
|
476 | (51,946 | ) | 12,560 | (19,145 | ) | ||||||||||
|
Net
income
|
$ | 69,403 | $ | 72,356 | $ | 141,256 | $ | 223,623 | ||||||||
|
Basic
net income per common share
|
$ | 0.38 | $ | 0.40 | $ | 0.77 | $ | 1.22 | ||||||||
|
Diluted
net income per common share
|
$ | 0.37 | $ | 0.39 | $ | 0.76 | $ | 1.19 | ||||||||
|
Dividends
declared per common share
|
$ | 0.340 | $ | 0.339 | $ | 1.018 | $ | 1.007 | ||||||||
|
Basic
common shares outstanding
|
183,856 | 181,963 | 183,301 | 183,414 | ||||||||||||
|
Diluted
common shares outstanding
|
187,861 | 183,999 | 186,770 | 187,661 | ||||||||||||
|
(1)
Includes share-based compensation expense as follows:
|
||||||||||||||||
|
Cost
of sales
|
$ | 1,266 | $ | 967 | $ | 4,845 | $ | 4,645 | ||||||||
|
Research
and development
|
3,108 | 2,948 | 9,205 | 8,023 | ||||||||||||
|
Selling,
general and administrative
|
4,463 | 4,250 | 13,285 | 11,689 | ||||||||||||
|
See
accompanying notes to condensed consolidated financial
statements
|
||||||||||||||||
|
Nine
Months Ended
December
31,
|
||||||||
|
2009
|
As
adjusted
2008
|
|||||||
|
Cash
flows from operating activities:
|
(See
Note 2)
|
|||||||
|
Net
income
|
$ | 141,256 | $ | 223,623 | ||||
|
Adjustments
to reconcile net income to net cash provided by operating
|
||||||||
|
activities:
|
||||||||
|
Depreciation
and amortization
|
67,735 | 72,210 | ||||||
|
Deferred
income taxes
|
15,466 | 4,920 | ||||||
|
Share-based
compensation expense related to equity incentive plans
|
27,335 | 24,357 | ||||||
|
Tax
benefit from equity incentive plans
|
2,089 | 11,239 | ||||||
|
Excess
tax benefit from share-based compensation
|
(2,050 | ) | (10,453 | ) | ||||
|
Convertible
debt derivatives - revaluation and amortization
|
154 | (1,153 | ) | |||||
|
Amortization
of convertible debenture issuance costs
|
302 | 575 | ||||||
|
Gain
on sale of assets
|
(100 | ) | (100 | ) | ||||
|
Special
charges
|
1,238 | 500 | ||||||
|
Sales/(purchases)
of trading securities, net
|
86,970 | (79,319 | ) | |||||
|
(Gain)
loss on trading securities
|
(7,425 | ) | 12,166 | |||||
|
Unrealized
impairment loss on available-for-sale investments
|
2,170 | 2,548 | ||||||
|
Changes
in operating assets and liabilities:
|
||||||||
|
(Increase)
decrease in accounts receivable
|
(25,238 | ) | 60,302 | |||||
|
Decrease
(increase) in inventories
|
19,216 | (10,966 | ) | |||||
|
Increase
in deferred income on shipments to distributors
|
13,652 | 2,980 | ||||||
|
Increase
(decrease) in accounts payable and accrued liabilities
|
14,600 | (18,446 | ) | |||||
|
Change
in other assets and liabilities
|
(13,351 | ) | (30,415 | ) | ||||
|
Net
cash provided by operating activities
|
344,019 | 264,568 | ||||||
|
Cash
flows from investing activities:
|
||||||||
|
Purchases
of available-for-sale investments
|
(1,311,946 | ) | (751,140 | ) | ||||
|
Sales
and maturities of available-for-sale investments
|
1,083,146 | 768,553 | ||||||
|
Investment
in other assets
|
(5,975 | ) | (15,023 | ) | ||||
|
Proceeds
from sale of assets
|
100 | 156 | ||||||
|
Capital
expenditures
|
(28,416 | ) | (91,821 | ) | ||||
|
Net
cash used in investing activities
|
(263,091 | ) | (89,275 | ) | ||||
|
Cash
flows from financing activities:
|
||||||||
|
Payment
of cash dividend
|
(186,594 | ) | (184,835 | ) | ||||
|
Repurchase
of common stock
|
--- | (123,929 | ) | |||||
|
Proceeds
from sale of common stock
|
18,578 | 26,476 | ||||||
|
Excess
tax benefit from share-based compensation
|
2,050 | 10,453 | ||||||
|
Net
cash used in financing activities
|
(165,966 | ) | (271,835 | ) | ||||
|
Net
decrease in cash and cash equivalents
|
(85,038 | ) | (96,542 | ) | ||||
|
Cash
and cash equivalents at beginning of period
|
446,329 | 487,736 | ||||||
|
Cash
and cash equivalents at end of period
|
$ | 361,291 | $ | 391,194 | ||||
|
See
accompanying notes to condensed consolidated financial
statements
|
||||||||
|
(1)
|
Basis of
Presentation
|
|
(2)
|
Adopted
and Recently Issued Accounting Pronouncements
|
|
Condensed
Consolidated Statements of Income:
|
||||||||||||||||
|
Three
Months Ended
December
31, 2008
|
Nine
Months Ended
December
31, 2008
|
|||||||||||||||
|
As
Reported
|
As
Adjusted
|
As
Reported
|
As
Adjusted
|
|||||||||||||
|
Interest
expense
|
$ | (5,775 | ) | $ | (7,096 | ) | $ | (17,758 | ) | $ | (21,608 | ) | ||||
|
Income
before income taxes
|
$ | 21,731 | $ | 20,410 | $ | 208,328 | $ | 204,478 | ||||||||
|
Income
tax benefit
|
$ | (51,438 | ) | $ | (51,946 | ) | $ | (17,663 | ) | $ | (19,145 | ) | ||||
|
Net
income
|
$ | 73,169 | $ | 72,356 | $ | 225,991 | $ | 223,623 | ||||||||
|
Basic
net income per common share
|
$ | 0.40 | $ | 0.40 | $ | 1.23 | $ | 1.22 | ||||||||
|
Diluted
net income per common share
|
$ | 0.40 | $ | 0.39 | $ | 1.20 | $ | 1.19 | ||||||||
|
Condensed
Consolidated Balance Sheet:
|
||||||||
|
March
31, 2009
|
||||||||
|
As Reported
|
As Adjusted
|
|||||||
|
Deferred
tax assets
|
$ | 69,626 | $ | 75,681 | ||||
|
Total
current assets
|
$ | 1,742,789 | $ | 1,748,844 | ||||
|
Other
assets
|
$ | 34,254 | $ | 18,526 | ||||
|
Total
assets
|
$ | 2,421,439 | $ | 2,411,766 | ||||
|
Junior
convertible debentures
|
$ | 1,149,184 | $ | 334,184 | ||||
|
Deferred
tax liability
|
$ | 51,959 | $ | 365,734 | ||||
|
Additional
paid-in capital
|
$ | 778,204 | $ | 1,273,876 | ||||
|
Retained
earnings
|
$ | 1,303,437 | $ | 1,299,317 | ||||
|
Total
stockholders' equity
|
$ | 990,766 | $ | 1,482,318 | ||||
|
Total
liabilities and stockholders' equity
|
$ | 2,421,439 | $ | 2,411,766 | ||||
|
Available-for-sale
Securities
|
||||||||||||||||
|
Adjusted
Cost
|
Gross
Unrealized Gains
|
Gross
Unrealized Losses
|
Estimated
Fair
Value
|
|||||||||||||
|
Government
agency bonds
|
$ | 417,264 | $ | 354 | $ | 1,381 | $ | 416,237 | ||||||||
|
Municipal
bonds
|
262,127 | 2,333 | --- | 264,460 | ||||||||||||
|
Auction
rate securities
|
16,731 | --- | --- | 16,731 | ||||||||||||
|
Corporate
bonds
|
409,515 | 3,304 | 1,136 | 411,683 | ||||||||||||
| $ | 1,105,637 | $ | 5,991 | $ | 2,517 | $ | 1,109,111 | |||||||||
|
Trading
Securities
|
||||||||||||||||
|
Adjusted
Cost
|
Gross
Unrealized Gains
|
Gross
Unrealized Losses
|
Estimated
Fair
Value
|
|||||||||||||
|
Auction
rate securities
|
$ | 26,500 | $ | --- | $ | --- | $ | 26,500 | ||||||||
|
Put
option on auction rate securities
|
2,700 | --- | --- | 2,700 | ||||||||||||
| $ | 29,200 | $ | --- | $ | --- | $ | 29,200 | |||||||||
|
Adjusted
Cost
|
Gross
Unrealized Gains
|
Gross
Unrealized Losses
|
Estimated
Fair
Value
|
|||||||||||||
|
Available-for-sale
|
||||||||||||||||
|
Due
in one year or less
|
$ | 380,558 | $ | 2,038 | $ | 31 | $ | 382,565 | ||||||||
|
Due
after one year and through five years
|
708,348 | 3,953 | 2,486 | 709,815 | ||||||||||||
|
Due
after five years and through ten years
|
--- | --- | --- | --- | ||||||||||||
|
Due
after ten years
|
16,731 | --- | --- | 16,731 | ||||||||||||
| $ | 1,105,637 | $ | 5,991 | $ | 2,517 | $ | 1,109,111 | |||||||||
|
|
Level
1 – Observable inputs such as quoted prices in active
markets;
|
|
|
Level
2 – Inputs, other than the quoted prices in active markets, that are
observable either directly or indirectly;
and
|
|
|
Level
3 – Unobservable inputs in which there is little or no market data, which
require the reporting entity to develop its own
assumptions.
|
|
Quoted
Prices in Active Markets for Identical Instruments
(Level
1)
|
Significant
Other
Observable
Inputs
(Level
2)
|
Significant
Unobservable
Inputs
(Level
3)
|
Total
Balance
|
|||||||||||||
|
Assets
|
||||||||||||||||
|
Money
market fund deposits
|
$ | 67,740 | $ | --- | $ | --- | $ | 67,740 | ||||||||
|
Deposit
accounts
|
--- | 293,551 | --- | 293,551 | ||||||||||||
|
Government
agency bonds
|
--- | 416,237 | --- | 416,237 | ||||||||||||
|
Municipal
bonds
|
--- | 264,460 | --- | 264,460 | ||||||||||||
|
Auction
rate securities
|
--- | --- | 43,231 | 43,231 | ||||||||||||
|
Put
option on auction rate securities
|
--- | --- | 2,700 | 2,700 | ||||||||||||
|
Corporate
bonds
|
--- | 411,683 | --- | 411,683 | ||||||||||||
|
Total
assets measured at fair value
|
$ | 67,740 | $ | 1,385,931 | $ | 45,931 | $ | 1,499,602 | ||||||||
|
Three
Months Ended December 31, 2009
|
Nine
Months Ended December 31, 2009
|
|||||||
|
Balance
at September 30, 2009 and March 31, 2009, respectively
|
$ | 47,784 | $ | 50,826 | ||||
|
Securities
redeemed at par
|
(1,325 | ) | (2,725 | ) | ||||
|
Impairment
losses included in interest income
|
(528 | ) | (2,170 | ) | ||||
|
Balance
at December 31, 2009
|
$ | 45,931 | $ | 45,931 | ||||
|
Quoted
Prices
in
Active
Markets
for
Identical
Instruments
(Level
1)
|
Significant
Other
Observable
Inputs
(Level
2)
|
Significant
Unobservable
Inputs
(Level
3)
|
Total
Balance
|
|||||||||||||
|
Assets
|
||||||||||||||||
|
Cash
and cash equivalents
|
$ | 67,740 | $ | 293,551 | $ | --- | $ | 361,291 | ||||||||
|
Short-term
investments
|
--- | 687,483 | 29,200 | 716,683 | ||||||||||||
|
Long-term
investments
|
--- | 404,897 | 16,731 | 421,628 | ||||||||||||
|
Total
assets measured at fair value
|
$ | 67,740 | $ | 1,385,931 | $ | 45,931 | $ | 1,499,602 | ||||||||
|
(6)
|
Fair Value of
Financial Instruments
|
|
(7)
|
Accounts
Receivable
|
|
December
31,
2009
|
March
31,
2009
|
|||||||
|
Trade
accounts receivable
|
$ | 116,326 | $ | 91,325 | ||||
|
Other
|
625 | 376 | ||||||
| 116,951 | 91,701 | |||||||
|
Less
allowance for doubtful accounts
|
3,188 | 3,176 | ||||||
| $ | 113,763 | $ | 88,525 | |||||
|
(8)
|
Inventories
|
|
December
31,
2009
|
March
31,
2009
|
|||||||
|
Raw
materials
|
$ | 4,863 | $ | 3,693 | ||||
|
Work
in process
|
97,314 | 114,676 | ||||||
|
Finished
goods
|
10,607 | 13,141 | ||||||
| $ | 112,784 | $ | 131,510 | |||||
|
(9)
|
Property, Plant and
Equipment
|
|
December
31,
2009
|
March
31,
2009
|
|||||||
|
Land
|
$ | 39,671 | $ | 39,671 | ||||
|
Building
and building improvements
|
347,625 | 334,717 | ||||||
|
Machinery
and equipment
|
1,166,684 | 1,148,588 | ||||||
|
Projects
in process
|
95,470 | 114,478 | ||||||
| 1,649,450 | 1,637,454 | |||||||
|
Less
accumulated depreciation
and
amortization
|
1,154,385 | 1,105,767 | ||||||
| $ | 495,065 | $ | 531,687 | |||||
|
(13)
|
Comprehensive
Income
|
|
Three
Months Ended
December
31,
|
Nine
Months Ended
December
31,
|
|||||||||||||||
|
2009
|
2008
|
2009
|
2008
|
|||||||||||||
|
Change
in unrealized gains and losses on investments, net of tax effect of $641,
($2,403), $1,616 and ($1,462), respectively
|
$ | 1,637 | $ | (5,968 | ) | $ | 1,600 | $ | (2,766 | ) | ||||||
|
(14)
|
Employee Benefit
Plans
|
|
Three
Months Ended
December
31,
|
Nine
Months Ended
December
31,
|
|||||||||||||||
|
2009
|
2008
|
2009
|
2008
|
|||||||||||||
|
Cost
of sales
|
$ | 1,266 | (1) | $ | 967 | (1) | $ | 4,845 | (1) | $ | 4,645 | (1) | ||||
|
Research
and development
|
3,108 | 2,948 | 9,205 | 8,023 | ||||||||||||
|
Selling,
general and administrative
|
4,463 | 4,250 | 13,285 | 11,689 | ||||||||||||
|
Pre-tax
effect of share-based compensation
|
8,837 | 8,165 | 27,335 | 24,357 | ||||||||||||
|
Income
tax benefit
|
1,180 | 1,454 | 3,585 | 4,384 | ||||||||||||
|
Net
income effect of share-based compensation
|
$ | 7,657 | $ | 6,711 | $ | 23,750 | $ | 19,973 | ||||||||
|
|
(1)
During the three and nine months ended December 31, 2009, $1.8 million and
$5.3 million, respectively, was capitalized to inventory and $1.3
million and $4.8
million, respectively, of previously capitalized inventory was
sold. During the three and nine months ended December 31, 2008,
$1.8
million
and $4.9 million, respectively, was capitalized to inventory and $1.0
million and $4.6 million, respectively, of previously capitalized
inventory was sold.
|
|
(15)
|
Net Income Per Common
Share
|
|
Three
Months Ended
December
31,
|
Nine
Months Ended
December
31,
|
|||||||||||||||
|
2009
|
2008
|
2009
|
2008
|
|||||||||||||
|
Net
income
|
$ | 69,403 | $ | 72,356 | $ | 141,256 | $ | 223,623 | ||||||||
|
Weighted
average common shares outstanding
|
183,856 | 181,963 | 183,301 | 183,414 | ||||||||||||
|
Dilutive
effect of stock options and RSUs
|
4,005 | 2,036 | 3,469 | 3,854 | ||||||||||||
|
Dilutive
effect of convertible debt
|
--- | --- | --- | 393 | ||||||||||||
|
Weighted
average common and potential common shares outstanding
|
187,861 | 183,999 | 186,770 | 187,661 | ||||||||||||
|
Basic
net income per common share
|
$ | 0.38 | $ | 0.40 | $ | 0.77 | $ | 1.22 | ||||||||
|
Diluted
net income per common share
|
$ | 0.37 | $ | 0.39 | $ | 0.76 | $ | 1.19 | ||||||||
|
(16)
|
Stock
Repurchase
|
|
(17)
|
Dividends
|
|
(18)
|
Subsequent
Event
|
|
Management's
Discussion and Analysis of Financial Condition and Results of
Operations
|
|
·
|
The
effects that adverse global economic conditions and fluctuations in the
global credit and equity markets may have on our financial condition and
results of operations;
|
|
|
·
|
The
effects and amount of competitive pricing pressure on our product
lines;
|
|
|
·
|
Our
ability to moderate future average selling price
declines;
|
|
|
·
|
The
effect of product mix, capacity utilization, yields, and fixed cost
absorption on gross margin;
|
|
|
·
|
The
amount of changes in demand for our products and those of our
customers;
|
|
|
·
|
The
level of orders that will be received and shipped within a
quarter;
|
|
|
·
|
The
effect that distributor and customer inventory holding patterns will have
on us;
|
|
|
·
|
Our
belief that deferred cost of sales will have low risk of material
impairment;
|
|
|
·
|
Our
belief that our direct sales personnel combined with our distributors
provide an effective means of reaching our customer
base;
|
|
|
·
|
Our
ability to increase the proprietary portion of our analog and interface
product lines and the effect of such an increase;
|
|
|
·
|
The
impact of any supply disruption we may experience;
|
|
|
·
|
Our
ability to effectively utilize our facilities at appropriate capacity
levels and anticipated costs;
|
|
| · | That we adjust capacity utilization to respond to actual and anticipated business and industry-related conditions; | |
|
·
|
That
our existing facilities and planned expansion activities provide
sufficient capacity to respond to increases in demand;
|
|
|
·
|
That
manufacturing costs will be reduced by transition to advanced process
technologies;
|
|
|
·
|
Our
expectation that our wafer fabs will operate at high levels with no
under-absorption of fixed costs;
|
|
|
·
|
Our
ability to maintain manufacturing yields;
|
|
|
·
|
Continuing
our investments in new and enhanced products;
|
|
|
·
|
Our
ability to attract and retain qualified personnel;
|
|
|
·
|
The
cost effectiveness of using our own assembly and test
operations;
|
|
|
·
|
Our
anticipated level of capital expenditures;
|
|
|
·
|
Continuation
and amount of quarterly cash dividends;
|
|
|
·
|
The
sufficiency of our existing sources of liquidity;
|
|
|
·
|
The
impact of seasonality on our business;
|
|
|
·
|
The
accuracy of our estimates used in valuing employee equity
awards;
|
|
|
·
|
That
the resolution of legal actions will not harm our business, and the
accuracy of our assessment of the probability of loss and range of
potential loss;
|
|
|
·
|
That
the idling of assets will not impair the value of such
assets;
|
|
|
·
|
The
recoverability of our deferred tax
assets;
|
|
·
|
The
adequacy of our tax reserves to offset any potential tax liabilities,
having the appropriate support for our income tax positions and the
accuracy of our estimated tax rate;
|
|
|
·
|
Our
belief that the expiration of any tax holidays will not have a material
impact;
|
|
|
·
|
The
accuracy of our estimates of the useful life and values of our property,
assets, and other liabilities;
|
|
|
·
|
The
adequacy of our patent strategy;
|
|
|
·
|
Our
ability to obtain patents and intellectual property licenses and minimize
the effects of litigation;
|
|
|
·
|
The
level of risk we are exposed to for product liability
claims;
|
|
|
·
|
The
amount of labor unrest, public health issues, political instability,
governmental interference and changes in general economic conditions that
we experience;
|
|
|
·
|
The
effect of fluctuations in market interest rates on income and/or cash
flows;
|
|
|
·
|
The
effect of fluctuations in currency rates;
|
|
|
·
|
Our
ability to collect accounts receivable;
|
|
|
·
|
Our
belief that our investments in student loan auction rate municipal bond
offerings are of high credit quality;
|
|
|
·
|
Our
ability to hold our fixed income investments and certain ARS until the
market recovers, and the immaterial impact this will have on our
liquidity;
|
|
|
·
|
Our
belief that unrealized losses in our investment portfolio do not represent
other-than-temporary impairment;
|
|
|
·
|
Our
belief that any future changes in the fair value of the ARS associated
with the ARS rights agreement will be largely offset by changes in the
fair value of the related rights without any significant net impact to our
income statement;
|
|
|
·
|
The
accuracy of our estimation of the cost effectivity of our insurance
coverage;
|
|
|
·
|
Our
belief that our activities are conducted in compliance with various
regulations not limited to environmental and export
compliance;
|
|
|
·
|
Our
ability and intent to settle the principal amount of the junior
subordinated convertible debentures in cash; and
|
|
|
·
|
The
accuracy of our estimates used in valuing our available-for-sale
securities.
|
|
|
indicated:
|
|
Three
Months Ended
December
31,
|
Nine
Months Ended
December
31,
|
|||||||||||||||
|
2009
|
2008
|
2009
|
2008
|
|||||||||||||
|
Net
sales
|
100.0 | % | 100.0 | % | 100.0 | % | 100.0 | % | ||||||||
|
Cost
of sales
|
41.6 | 45.5 | 45.4 | 40.7 | ||||||||||||
|
Gross
profit
|
58.4 | 54.5 | 54.6 | 59.3 | ||||||||||||
|
Research
and development
|
12.1 | 14.0 | 13.0 | 12.3 | ||||||||||||
|
Selling,
general and administrative
|
17.3 | 19.2 | 18.0 | 17.5 | ||||||||||||
|
Special
charge
|
--- | 0.2 | 0.2 | 0.1 | ||||||||||||
|
Operating
income
|
29.0 | % | 21.1 | % | 23.4 | % | 29.4 | % | ||||||||
|
|
·
|
global
economic conditions in the markets we
serve;
|
|
|
·
|
semiconductor
industry conditions;
|
|
|
·
|
inventory
holding patterns of our customers;
|
|
|
·
|
increasing
semiconductor content in our customers'
products;
|
|
|
·
|
customers'
increasing needs for the flexibility offered by our programmable
solutions;
|
|
|
·
|
our
new product offerings that have increased our served available market;
and
|
|
|
·
|
continued
market share gains.
|
|
Three
Months Ended
December
31,
(unaudited)
|
Nine
Months Ended
December
31,
(unaudited)
|
|||||||||||||||||||||||||||||||
|
2009
|
%
|
2008
|
%
|
2009
|
%
|
2008
|
%
|
|||||||||||||||||||||||||
|
Microcontrollers
|
$ | 202,416 | 80.9 | % | $ | 155,866 | 81.1 | % | $ | 544,477 | 81.3 | % | $ | 590,558 | 80.9 | % | ||||||||||||||||
|
Memory
products
|
21,182 | 8.5 | 17,341 | 9.0 | 56,999 | 8.5 | 73,671 | 10.1 | ||||||||||||||||||||||||
|
Analog
and interface products
|
26,501 | 10.6 | 18,959 | 9.9 | 68,233 | 10.2 | 65,815 | 9.0 | ||||||||||||||||||||||||
|
Total
sales
|
$ | 250,099 | 100.0 | % | $ | 192,166 | 100 .0 | % | $ | 669,709 | 100.0 | % | $ | 730,044 | 100.0 | % | ||||||||||||||||
|
Three
Months Ended
December
31,
(unaudited)
|
Nine
Months Ended
December
31,
(unaudited)
|
|||||||||||||||||||||||||||||||
|
2009
|
%
|
2008
|
%
|
2009
|
%
|
2008
|
%
|
|||||||||||||||||||||||||
|
Americas
|
$ | 59,311 | 23.7 | % | $ | 50,836 | 26.4 | % | $ | 164,678 | 24.6 | % | $ | 181,587 | 24.9 | % | ||||||||||||||||
|
Europe
|
60,059 | 24.0 | 52,802 | 27.5 | 164,062 | 24.5 | 203,955 | 27.9 | ||||||||||||||||||||||||
|
Asia
|
130,729 | 52.3 | 88,528 | 46.1 | 340,969 | 50.9 | 344,502 | 47.2 | ||||||||||||||||||||||||
|
Total
sales
|
$ | 250,099 | 100.0 | % | $ | 192,166 | 100.0 | % | $ | 669,709 | 100.0 | % | $ | 730,044 | 100.0 | % | ||||||||||||||||
|
|
·
|
production
levels being below the range of our normal capacity resulting in under
absorption of fixed costs; and
|
|
|
·
|
continual
cost reductions in wafer fabrication and assembly and test manufacturing,
such as new manufacturing technologies and more efficient manufacturing
techniques.
|
|
|
·
|
inventory
write-downs partially offset by sales of inventory that was previously
written down;
|
|
|
·
|
lower
depreciation as a percentage of cost of sales;
and
|
|
|
·
|
fluctuations
in the product mix of microcontrollers, proprietary and non-proprietary
analog products and Serial EEPROM products resulting in lower overall
average selling prices for our
products.
|
|
Quantitative
and Qualitative Disclosures About Market
Risk
|
|
Controls
and Procedures
|
|
Legal
Proceedings
|
|
Item 1A
.
|
Risk
Factors
|
|
|
·
|
changes
in demand or market acceptance of our products and products of our
customers;
|
|
|
·
|
levels
of inventories at our customers;
|
|
|
·
|
the
mix of inventory we hold and our ability to satisfy orders from our
inventory;
|
|
|
·
|
changes
in utilization of our manufacturing capacity and fluctuations in
manufacturing yields;
|
|
|
·
|
our
ability to secure sufficient assembly and testing
capacity;
|
|
|
·
|
availability
of raw materials and equipment;
|
|
|
·
|
competitive
developments including pricing
pressures;
|
|
|
·
|
the
level of orders that are received and can be shipped in a
quarter;
|
|
|
·
|
the
level of sell-through of our products through
distribution;
|
|
|
·
|
fluctuations
in the mix of products;
|
|
|
·
|
changes
or fluctuations in customer order patterns and
seasonality;
|
|
|
·
|
constrained
availability from other electronic suppliers impacting our customers'
ability to ship their products, which in turn may adversely impact our
sales to those customers;
|
|
|
·
|
costs
and outcomes of any current or future tax audits or any litigation
involving intellectual property, customers or other
issues;
|
|
|
·
|
changes
in tax regulations and policies in the U.S. and other countries in which
we do business;
|
|
|
·
|
disruptions
in our business or our customers' businesses due to terrorist activity,
armed conflict, war, worldwide oil prices and supply, public health
concerns or disruptions in the transportation
system;
|
|
|
·
|
fluctuations
in commodity prices;
|
|
|
·
|
general
economic, industry or political conditions in the U.S. or
internationally.
|
|
|
·
|
the
quality, performance, reliability, features, ease of use, pricing and
diversity of our products;
|
|
|
·
|
our
success in designing and manufacturing new products including those
implementing new technologies;
|
|
|
·
|
the
rate at which customers incorporate our products into their own
applications;
|
|
|
·
|
product
introductions by our competitors;
|
|
|
·
|
the
number, nature and success of our competitors in a given
market;
|
|
|
·
|
our
ability to obtain adequate supplies of raw materials and other supplies at
acceptable prices;
|
|
|
·
|
our
ability to protect our products and processes by effective utilization of
intellectual property rights;
|
|
|
·
|
our
ability to address the needs of our customers;
and
|
|
|
·
|
general
market and economic conditions.
|
|
|
·
|
proper
new product selection;
|
|
|
·
|
timely
completion and introduction of new product
designs;
|
|
|
·
|
availability
of development and support tools and collateral literature that make
complex new products
easy
for engineers to understand and use;
and
|
|
|
·
|
market
acceptance of our customers' end
products.
|
|
|
·
|
costs
related to writing off the value of inventory of nonconforming
products;
|
|
|
·
|
recalling
nonconforming products;
|
|
|
·
|
providing
support services, product replacements, or modifications to products and
the defense of such claims;
|
|
|
·
|
diversion
of resources from other projects;
|
|
|
·
|
lost
revenue or a delay in the recognition of revenue due to cancellation of
orders and unpaid receivables;
|
|
|
·
|
customer
imposed fines or penalties for failure to meet contractual requirements;
and
|
|
|
·
|
a
requirement to pay damages.
|
|
|
·
|
political,
social and economic instability;
|
|
|
·
|
public
health conditions;
|
|
|
·
|
trade
restrictions and changes in
tariffs;
|
|
|
·
|
import
and export license requirements and
restrictions;
|
|
|
·
|
difficulties
in staffing and managing international
operations;
|
|
|
·
|
employment
regulations;
|
|
|
·
|
disruptions
in international transport or
delivery;
|
|
|
·
|
difficulties
in collecting receivables;
|
|
|
·
|
economic
slowdown in the worldwide markets served by us;
and
|
|
|
·
|
potentially
adverse tax consequences.
|
|
·
|
quarterly
variations in our operating results and the operating results of other
technology companies;
|
|
·
|
actual
or anticipated announcements of technical innovations or new products by
us or our competitors;
|
|
·
|
changes
in analysts' estimates of our financial performance or buy/sell
recommendations;
|
|
·
|
changes
in our financial guidance or our failure to meet such
guidance;
|
|
·
|
any
acquisitions we pursue or complete;
|
|
·
|
general
conditions in the semiconductor industry;
and
|
|
·
|
global
economic and financial conditions.
|
|
2.1
|
Agreement
and Plan of Merger, dated as of February 2, 201, by and among Microchip
Technology Incorporated,
Sun Acquisition Corporation and Silicon Storage Technology,
Inc.
(1)
|
|
31.1
|
Certification
of Chief Executive Officer Pursuant to Section 302 of the Sarbanes-Oxley
Act of 2002.
|
|
31.2
|
Certification
of Chief Financial Officer Pursuant to Section 302 of the Sarbanes-Oxley
Act of 2002.
|
|
32
|
Certification
of Chief Executive Officer and Chief Financial Officer Pursuant to Section
906 of the Sarbanes-Oxley Act of
2002.
|
|
MICROCHIP
TECHNOLOGY INCORPORATED
|
|
|
Date: February
9,
2010
|
By:
/s/ J.
Eric
Bjornholt
|
|
J. Eric
Bjornholt
|
|
|
Vice President and Chief
Financial Officer
|
|
|
(Duly Authorized Officer,
and
|
|
|
Principal Financial
and Accounting Officer)
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|